A model for the structural organization of aminoacyl-tRNA synthetases in mammalian cells  by Çirakoḡlu, Beyazit et al.
Volume 185, number 2 FEBS 2441 April 1985 
Hype thesis 
A model for the structural organization of aminoacyl-tRNA 
synthetases in mammalian cells 
Beyazlt Qrakoglu *, Marc Mirande and Jean-Pierre Wailer“ 
Laboratoire de Biochimie, Ecole P&technique, Unit& 245 Associ&e au Centre National de la Recherche Scienttj?que, 91128 
Palaiseau Cedex, France 
Received 4February 1985 
Animal ce!I Aminoacyi-tRNA syrtthetase 
1. INTRODUCTION 
The occurrence of high& complexes of 
aminoacyl-tRNA synthetases from animal cells has 
been extensively documents over the past 15 years 
(reviews [1,2J). However, because of the disparate 
results reported concerning the composition and 
properties of these multienzyme complexes, their 
biological significance and structural organization 
have been difficult to comprehend. 
A general model for the organization of these 
complexes was recently proposed by Deutscher 131. 
The model supposes that the aminoacyf-tRNA syn- 
thetases from animal sources are amphipathic pro- 
teins composed of a hydrophilic catalytic domain 
and a hydrophobic domain that participates in 
complex formation. The suggestion is made that 
the enzymes are held together by a core composed 
of the hydrophobic extensions present on the in- 
dividual proteins, with their catalytic centers ex- 
posed to the environment. Moreover, the possibili- 
ty is considered that in vivo, the aminoacyl-tRNA 
synthetases may be associated with membranes 131. 
Although this model may account for many of the 
findings reported in the literature, it fails to pro- 
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vide a satisfactory explanation for the general 
observation that several of the 20 ~inoacyl-tRNA 
synthetases are, at best, only encountered as com- 
ponents of highly fragile supra-molecular 
assemblies, but never as part of stable complexes 
amenable to purification by conventional 
procedures. 
The object of this paper is to propose an alter- 
native model for the strirctural organization of 
aminoacyl-tRNA synthetases in mammalian cells, 
which accommodates the observed differences in 
behaviour among these 20 enzymes, Since the 
published data pertaining to these multienzyme 
complexes have been recently compiled 141 and 
reviewed [1,2], the model will be presented with 
reference to these reviews, citing only a few other 
relevant and recent reports. 
2. CHARACTERISTICS OF 
AMINOACYL-tRNA SYNTHETASE 
COMPLEXES ISOLATED FROM 
ANIMAL CELLS 
Several laboratories described large complexes 
comprising all or most of the 20 ~inoacyl-tRNA 
synthetases, often containing other components as 
well, such as tRNA, lipids, elongation factors and 
tRNA modification enzymes (tabulation in [4]). 
Such fragile complexes were generally observed in 
extracts from cells lysed under gentIe conditions, at 
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low ionic strength. Attempts to purify these ag- 
gregates invariably led to breakdown into smaller 
‘core’ complexes, with concomitant release of cer- 
tain aminoacyl-tRNA synthetases as ‘free’ en- 
zymes, It follows that there has been no ex- 
perimental evidence to support the view that all 20 
aminoacyl-tRNA synthetases may be physically 
associated within one large multienzyme complex. 
However, at the least, these findings indicate that 
all of the aminoacyl-tRNA synthetases possess the 
aptitude to associate with other components, albeit 
with different affinities. 
Hardesty and co-workers [5] examined the 
subcellular distribution of 19 aminoacyl-tRNA 
synthetases in several eukaryotic cells (rabbit 
reticulocytes, mouse liver and embryo, chicken 
embryo, Friend leukemia cells and HeLa cells) 
under standard conditions of sample preparation. 
Sucrose gradient centrifugation of the post- 
ribosomal supernatant from each of these cell 
types showed that 10 aminoacyl-tRNA syn- 
thetases, soecific for Arg, Asp, Glu, Gln, Ile, Leu, 
Lys, Met, Pro and Val, henceforth referred to as 
class I enzymes, sedimented mainly in the 18-25 S 
region of the gradient, while 9 others, specific for 
Ala, Asn, Cys, Gly, His, Phe, Ser, Thr and Tyr 
(class II) were present predominantly in the 4-9 S 
region of the gradient. Essentially similar sedimen- 
tation patterns were reported for the aminoacyl- 
tRNA synthetases from Chinese hamster ovary 
(CHO) cells [6] and rat skeletal muscle and liver 
171. 
Several laboratories have reported the purifica- 
tion of high-Mr complexes from different sources, 
using conventional fractionation procedures 
(tabulation in [ 1,3,4]). Although these complexes 
contained a variable number of aminoacyl-tRNA 
synthetases, it is noteworthy that the enzymes pre- 
sent invariably belonged to class I. Recent progress 
in purification procedures has allowed us to isolate 
an apparently ubiquitous multienzyme complex 
from CHO cells [8], rabbit liver and reticulocytes 
[9] as well as rat liver [lo]. Each of these highly 
purified complexes contained the same 9 
aminoacyl-tRNA synthetases corresponding to 
class I, specific for Arg, Asp, Glu, Gln, IIe, Leu, 
Lys, Met and Pro. Moreover, SDS-polyacrylamide 
gel electrophoresis revealed virtually identical 
polypeptide patterns composed of 12 components, 
8 of which were assigned to constituent aminoacyl- 
186 
tRNA synthetases (fig.1). A complex of very 
similar composition was also purified from sheep 
liver [9]. It differed from the above essentially by 
the absence of prolyl-tRNA synthetase [8], and by 
the presence of glutamyl-tRNA synthetase as a 
polypeptide of M, 85 000 instead of h4, 150000 
[l 11, possibly a consequence of uncontrolled pro- 
teolysis. Furthermore, in the case of CHO cells, we 
showed that when the crude extract from 
metabolically [35S]methionine-labeled cells was 
subjected to immunoprecipitation with antibodies 
directed to the purified complex from sheep liver, 
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Fig. 1. Polypeptide compositions of the purified 
aminoacyl-tRNA synthetase complexes from various 
animal species. The purified complexes from rabbit liver 
(A) and reticulocytes (B) [9], rat liver (C) [lo], CHO cells 
(D) [8] and sheep liver (E) [9] were subjected to SDS- 
polyacrylamide g l electrophoresis, followed by staining 
with Coomassie brilliant blue R250. The apparent M, 
and aminoacyl-tRNA synthetase assignment of the 
polypeptides from rabbit liver (left side) and sheep liver 
(right side) are from [ 111. It was verified, by the protein 
blotting procedure, that the polypeptides from rabbit, 
rat and CHO cells which display identical or similar 
mobilities correspond to the same aminoacyl-tRNA 
synthetase [8, lo]. Unidentified polypeptides are 
designated by an asterisk. 
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or to its homogeneous methionyl- or lysyl-tRNA 
synthetase components, the polypeptide composi- 
tions of the immunoprecipitates recovered were 
virtually indistinguishable from that of the com- 
plex purified by conventional procedures [8]. This 
not only demonstrates that the polypeptide com- 
ponents which characterize these purified com- 
plexes are associated within the same particle, but 
also constitutes the strongest evidence so far in 
support of the existence of this ubiquitous complex 
as a discrete, biologically relevant entity. In par- 
ticular, this result seems difficult to reconcile with 
the often expressed view (e.g., [12]) that the 
purified stable complexes represent ‘core’ struc- 
tures arising from dissociation of the more loosely 
bound aminoacyl-tRNA synthetases from a single 
large multienzyme complex comprising each of 
these enzymes. Further evidence for the distinction 
between class I and II enzymes came from studies 
in which the size distribution of each of the 20 
aminoacyl-tRNA synthetases in the extract from 
CHO cells was examined by gel filtration on Bio- 
Gel A-5m equilibrated in 100 mM phosphate buf- 
fer [8]. Nine aminoacyl-tRNA synthetases, the 
same as those found in the purified complex, were 
co-eluted as a peak corresponding to an apparent 
M, of - 1.2 x 106. Seven of these enzymes occurred 
exclusively as high-M, entities, only arginyl- and 
aspartyl-tRNA synthetase giving rise to an addi- 
tional, low-M, form representing about 25% of the 
total activity recovered. Of the 11 remaining 
aminoacyl-tRNA synthetases, all except valyl- 
tRNA synthetase were eluted as single peaks cor- 
responding to apparent M, values characteristic of 
‘free’ enzymes, ranging from about 100000 for 
tryptophanyl-tRNA synthetase, to about 250000 
for phenylalanyl- and cysteinyl-tRNA synthetases. 
Valyl-tRNA synthetase was the only other enzyme 
which occurred as a high-M, entity, the size of 
which was distinctly lower than that of the other 
high-M, enzymes. The latter enzyme has not been 
characterized to date, and will thus not be dis- 
cussed further. 
That hydrophobic interactions may play a pro- 
minent role in the assembly of the stable multien- 
zyme complexes was strongly suggested by indirect 
evidence, such as the partial destabilization of the 
multienzyme complex from rat liver by 
hydrophobic interaction chromatography [ 131 or 
by the synergistic action of neutral detergents and 
chaotropic salts [14]. Direct evidence was recently 
obtained by showing that leucyl- and lysyl-tRNA 
synthetases [15], as well as isoleucyl-tRNA syn- 
thetase (Lazard, Mirande and Waller, submitted), 
derived from the complex from sheep liver and 
purified to homogeneity, displayed markedly 
hydrophobic properties. Moreover, in the case of 
lysyl-tRNA synthetase, it was shown that a fully 
active proteolytically modified form, similar in size 
to the corresponding prokaryotic enzyme, had lost 
the hydrophobic property [ 151, establishing the ex- 
istence of a hydrophobic domain distinct from the 
catalytic domain, as was proposed in [3]. Further- 
more, hydrophobic interaction chromatography of 
the purified complex from sheep liver on hexyl- 
agarose showed that leucyl- and lysyl-tRNA syn- 
thetases were the least hydrophobic components of 
this complex [15]. 
3. MODEL FOR THE STRUCTURAL 
ORGANIZATION OF MAMMALIAN 
AMINOACYL-tRNA SYNTHETASES 
IN VIVO 
In the light of the foregoing considerations, we 
propose that the class I aminoacyl-tRNA syn- 
thetases from animal cells have acquired 
hydrophobic properties, leading to the integration 
of 9 of them into an ubiquitous, structurally stable 
multienzyme complex. We further assume that the 
class II enzymes have not acquired hydrophobic 
properties and thus are not implicated in the for- 
mation of stable complexes. Several arguments 
support the latter contention. Firstly, class II en- 
zymes have never been found as components of 
purified, stable complexes (tabulation in [1,3,4]). 
Secondly, several of these enzymes which have 
been purified to homogeneity from various animal 
cells (seryl- [16], threonyl- [17], tryptophanyl- [18] 
and histidyl-tRNA synthetases [191) display pro- 
perties characteristic of hydrophilic enzymes. 
Thirdly, homogeneous tryptophanyl-tRNA syn- 
thetase from beef pancreas, which is not a consti- 
tuent of stable complexes, does not bind to phenyl- 
Sepharose in conditions in which leucyl-tRNA syn- 
thetase, a component of the stable multienzyme 
complex from sheep liver, displays strong affinity 
for this hydrophobic support [15]. 
It remains that class II enzymes do possess the 
capacity to associate with other components, albeit 
187 
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weakly, as demonstrated by the isolation of fragile 
supra-molecular aggregates containing all or most 
of the aminoacyl-tRNA synthetases 141. Moreover, 
while the functional significance of these 
assemblies is not understood in any detail, it has 
been generally considered [l-4] that they may be 
representative of a supra-molecular organization 
of the whole protein synthetic machinery in vivo. 
This implicitly assumes that each of the 20 
aminoacyl-tRNA synthetases must be involved in 
this organization. Our model for the structural 
organization of aminoacyl-tRNA synthetases 
within the cytoplasm of animal cells proposes that 
all aminoacyl-tRNA synthetases, including the 
class I enzymes pre-assembled as a stable multien- 
zyme complex through hydrophobic interactions, 
are associated with cellular components at or near 
the site of protein synthesis, by electrostatic 
interactions. 
Spirin and co-workers (review 1201) observed 
that in higher eukaryotes, a variety of proteins in- 
volved in protein biosynthesis, including initiation 
and elongation factors [21,22] as well as varying 
proportions of each of the 20 aminoacyl-tRNA 
synthetases [23,24], displayed the property of bind- 
ing to immobilized ribosomal RNA or synthetic 
polynucleotides in vitro. The finding that in the 
same conditions, the corresponding proteins from 
prokaryotes did not display this property led to the 
postulate that the RNA-binding property was an 
evolutionary acquisition of those eukaryotic pro- 
teins, to ensure their confinement at the site of 
utilization, in response to the increased cellular 
volume [25]. Later studies showed that immo- 
bilized heparin was equally effective in selectively 
retaining those proteins [26,27], suggesting that the 
polyanionic character alone was responsible for 
binding to these carriers. We recently showed [28] 
that the aminoacyl-tRNA synthetases from the 
lower eukaryote yeast, like the corresponding en- 
zymes from animal cells but unlike those of pro- 
karyotic origin, bind to polyanionic carriers in 
vitro, through ionic interactions. The general 
observation that lower eukaryotic aminoacyl- 
tRNA synthetases invariably possess longer 
polypeptide chains than do their prokaryotic 
homologues [29] suggested a possible relationship 
between chain elongation and the capacity to bind 
to polyanionic supports. This correlation was 
clearly established in the case of yeast lysyl-tRNA 
188 
synthetase, by showing that a proteolytically de- 
rived fully active form of the enzyme, similar in 
size to the corresponding prokaryotic enzyme, had 
lost the ability to bind to polyanionic supports 
[28]. Arguing that the evolutionary acquisition of 
this property by all lower eukaryotic aminoacyl- 
tRNA synthetases was unlikely to be fo~uitous 
and thus probably served an important function in 
vivo unrelated to catalysis, we suggested that it 
promotes the compartmentalization of these en- 
zymes within the cytoplasm, through electrostatic 
associations with as yet undefined, negatively 
charged cellular components, at or near the site of 
protein synthesis [28]. The observation that all of 
the class II enzymes from animal cells which have 
been purified to date display structural parameters 
nearly identical to those of the corresponding en- 
zymes from lower eukaryotes (tabulation in [ 1 I]), 
as well as the finding that the aminoacyl-tRNA 
synthetases from animal cells display the property 
of binding to polyanionic carriers f23,24], support 
the view that the above considerations may well 
apply to aminoacyl-tRNA synthetases from animal 
cells. 
The present model proposes that class II 
aminoacyl-tRNA synthetases associate with 
subcellular structures individually, while the class I 
enzymes bind as a pre-assembled complex. This 
would account for the observed fragility of the 
supra-molecular complexes, which are readily 
dissociated into ‘free’ enzymes and stable ‘core’ 
complexes, notably by more drastic extraction con- 
ditions or by elevating the ionic strength of the ex- 
traction medium. Moreover, the finding that other 
components of the protein biosynthesis machinery 
from higher eukaryotes also display the ability to 
bind to polyanionic carriers in conditions where 
their prokaryotic counterparts do not [21,22] may 
account for the fact that non-synthetase com- 
ponents, such as elongation factors or tRNA modi- 
fying enzymes, were occasionally reported as com- 
ponents of these fragile supra-molecular 
assemblies [4]. 
It is known that the purified high-M, complexes 
from sheep and rabbit bind strongly to the polya- 
nionic carriers heparin-Ultrogel or tRNA- 
Sepharose [9]. Suggestions concerning the mode of 
electrostatic association of these complexes with 
negatively charged carriers were presented in fI5]. 
We recently showed that when normal rat kidney 
Volume 183, number 2 FEBS LETTERS April I985 
(NRK) cells were extracted with Triton X-100, a 
substantial proportion of the high-A,& complex re- 
mained bound to the remnant cytoskeletal 
framework fraction, through ionic interactions 
[30]. Furthermore, immunocytological studies by 
double indirect immunofluorescence microscopy 
revealed an association of the complex with as yet 
unidentified components of the endoplasmic 
reticulum f30], in agreement with earlier results by 
Dang et al. ]31]. Whatever the nature of the 
cellular components implicated in this association, 
our model supposes that the class II enzymes 
would bind to these components individually, 
through ionic interactions. 
Although our model explicitly differentiates the 
class 1 and If aminoacyl-tRNA synthetases with 
regard to their mode of association with 
subcellular structures, the reason why only certain 
mammalian aminoacyl-tRNA synthetases would 
have acquired hydrophobic properties allowing 
their pre-assembly as a stable multienzyme com- 
plex remains obscure. No underlying physiological 
or biochemical principle has yet been recognized to 
account for the nature of the aminoacyl-tRNA 
synthetases implicated. Moreover, evidence was 
presented that no catalytic advantage was accrued 
from their integration into a complex, at least in 
vitro 132) _ 
Our comparative studies on leucyl- and lysyl- 
tRNA synthetases from yeast and animal cells 
clearly suggest hat the formation of stable mul- 
tienzyme complexes is conditioned by the evolu- 
tionary acquisition of hydrophobic properties [ 151. 
Indeed, those lower eukaryotic enzymes which do 
not form stable complexes [33,34] also do not bind 
to hydrophobic supports in conditions where their 
mammalian counterparts, derived from the mul- 
tienzyme complex, are strongly bound. If the selec- 
tive pressure for acquisition of hydrophobic pro- 
perties were related to stabilizing of the ‘loose’ net- 
work of aminoacyl-tRNA synthetases elec- 
trostatically bound to cellular components, by 
establishing interconnections between these en- 
zymes through hydrophobic interactions, the 
possibility may be envisaged that at the stage of 
evolution representative of mammals, certain 
aminoacyl-tRNA synthetases have yet to acquire 
this property. This, in turn, would suggest hat in 
more distantly related vertebrate species, such as 
fish or birds, the structural organization of 
aminoacyl-tRNA synthetases may differ from that 
of mammals. 
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